Ventricular Assist Devices Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Jarvik Heart, Inc., EVAHEART, INC., Cirtec, CorWave SA, Teleflex Incorporated

Ventricular Assist Devices Market is expected to grow at a CAGR of 10% during the forecast period 2024-2031

DataM Intelligence has published a new research report on "Ventricular Assist Devices Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/ventricular-assist-devices-market?sg

Key Players: Abbott Laboratories, Abiomed Inc, Berlin Heart GmbH, Medtronic Plc, Jarvik Heart, Inc., EVAHEART, INC., Cirtec, CorWave SA, Calon Cardio-Technology Ltd, and Teleflex Incorporated.

United States - Industry Latest News:

✅ Product Launch: On May 28, 2025, Dr. Paul Jansz and his team at St. Vincent Hospital in Sydney performed the first implantation of CorWave's next-generation left ventricular assist device (LVAD), marking a significant advancement in VAD technology.

✅ Clinical Trial: In May 2025, the first U.S. clinical trial commenced to evaluate the safety and efficacy of the BrioVAD System, an alternative to the HeartMate 3 LVAD, featuring fully magnetically levitated pump technology.

✅ FDA Recall: In April 2025, Abbott initiated a recall of certain HeartMate Mobile Power Units due to instances of sudden power loss, identified as the most serious type of medical device recall by the FDA.

✅ Hospital Milestone: On June 27, 2025, The Valley Hospital successfully implanted its first left ventricular assist device (LVAD), supporting heart function and blood flow in a patient with advanced heart failure.

Global Developments

✅ Strategic Merger: On October 15, 2025, MicroPort CRM announced a strategic merger with MicroPort CardioFlow Medtech Corporation, valued at US$680 million, to expand its presence in the cardiac rhythm management and heart failure markets.

✅ Clinical Innovation: On October 22, 2025, researchers at Mass General Brigham reported the first successful use of a heart-targeting adeno-associated virus (AAV) delivery platform in heart failure patients, advancing cardiac gene therapy.

✅ Technological Advancement: In September 2025, FineHeart's FlowMaker device, a turbine-based LVAD designed to assist native heart contraction with low energy consumption, began clinical trials in France, aiming for CE marking by 2028.

✅ Pediatric Program Expansion: In 2025, the Children's Hospital Los Angeles expanded its Pediatric Ventricular Assist Device Program, providing temporary mechanical circulatory support for children awaiting heart transplants.

Growth Forecast Projected:

The Global Ventricular Assist Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Ventricular Assist Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=ventricular-assist-devices-market?sg

Key Segments:

By Product Type (Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device)

By Design (Implantable Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices)

By Application (Bridge to Candidacy Therapy, Bridge to Transplant Therapy, Bridge to Recovery Therapy, Destination Therapy)

By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Ventricular Assist Devices producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Ventricular Assist Devices revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/ventricular-assist-devices-market?sg

FAQ's

Q1: Which regions are dominating the Ventricular Assist Devices market and which are fastest-growing?

A: North America is expected to hold a significant position in the global ventricular assist devices market share.

Q2: How fast is the Ventricular Assist Devices Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 10% from 2024-2031

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/ventricular-assist-devices-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.